Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksD4T4.L Regulatory News (D4T4)

  • There is currently no data for D4T4

Contract Wins

29 Jun 2022 07:00

RNS Number : 5177Q
D4T4 Solutions PLC
29 June 2022
 

29 June 2022

 

D4t4 Solutions Plc

 

Contract wins demonstrate the versatility and breadth of the Group's Celebrus CDP and FDP products.

 

D4t4 Solutions Plc (AIM: D4t4, "the Group", "D4t4"), the AIM-listed data solutions provider, is delighted to announce two new contracts, demonstrating the versatility and breadth of the Group's Celebrus CDP and FDP products.

The first contract is the sale of Celebrus CDP to a US-based health and financial services group. This sale has been made direct to a new customer for D4T4, though the process has been in close cooperation with a key partner. The contract is for a three-year term with optional renewals at annual intervals. The customer has struggled to obtain real-time data across its digital presence and Celebrus CDP will enable it to activate an improved end-customer experience and promote revenue opportunities. A key element to this win was Celebrus CDP's ability to operate within the demanding compliance requirements of HIPAA1, demonstrating a core feature of the Celebrus CDP proposition. The install location will be within the Celebrus Cloud, a single-tenant private cloud environment hosted by D4t4.

The second contract is the upsell of Celebrus FDP biometrics functionality to an existing Celebrus CDP customer which is a UK-based online retailer with 2.2 million daily website visits. This upsell demonstrates the cross-over for web-based businesses in not only improving the customer experience and generating more revenues by using Celebrus CDP, but also the need to protect their business and their customers from potential fraud, using Celebrus FDP. This install location will also be in the Celebrus Cloud environment. This contract is an upsell of an existing multi-year deal.

The two contracts have a combined total contract value of just over £1 million and Annual Recurring Revenue of just over £0.3 million per annum.

 

1 HIPAA refers to the Health Insurance Portability and Accountability Act, a United States Federal statute that sets standards for the lawful use and disclosure of protected health information in the United States.

 

Commenting on the contract wins, Bill Bruno, CEO of D4t4 Solutions, said:

"We work closely with customers and prospects to ensure that we can meet their needs, so making our products complementary and adaptable across multiple verticals is critical. These two contract wins clearly demonstrate the success of that approach and highlight the differentiators we have in the market today.

Celebrus CDP's ability to operate within the highly regulated US healthcare market was a key client requirement; in a world of increasing regulatory complexity we see this as key differentiator for us. The upsell of Celebrus FDP to an existing client demonstrates the ever-growing need to protect customers from fraud across all digital devices as well as the cross-selling potential within the Group as we look to drive our key ARR metric."

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as retained and applicable in the UK pursuant to S3 of the European Union (Withdrawal) Act 2018 ("MAR").

 

 

Enquiries

 

D4t4 Solutions Plc

Bill Bruno, Chief Executive Officer

Ash Mehta, Chief Financial Officer

 

+44 (0) 1932 893333

investors@d4t4solutions.com

 

 

finnCap (Nominated Adviser & Joint Broker)

Julian Blunt / Edward Whiley, Corporate Finance

Alice Lane, ECM

 

+44 (0) 20 7220 0500

Canaccord Genuity (Joint Broker)

Simon Bridges / Andrew Potts

 

+44 (0) 20 7523 8000

Instinctif Partners

Rozi Morris / Joe Quinlan

+44 (0) 20 7457 2020

D4t4Solutions@instinctif.com

 

About D4t4 Solutions plc

 

D4t4 Solutions plc (AIM: D4t4) was founded around a passion for helping global enterprises derive value from their data assets.

 

Supporting customers in financial services, retail, travel, healthcare, and telecommunications across 27 countries, D4t4 enables businesses to make smarter, informed decisions via Celebrus, the Group's flagship first party data product suite. Celebrus CDP automatically captures, contextualises, and activates user-based behavioural data in real-time across all digital channels. Through behavioural biometrics and analytics, Celebrus FDP helps companies prevent fraud before it happens. Celebrus CDM provides an enterprise platform ***that automates the integration and transformation of customer data from all relevant data sources, whether on-premises or cloud, to deliver customer and regulatory analytics.

 

The Group has offices in the UK, USA, India, and Australia with key talent in all markets to drive the growth of the business. Celebrus is fully compliant with all major data privacy regulations and the Group is accredited to ISO27001: Information Security Management.

 

For more information, please see www.d4t4solutions.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUWASRUOUNUAR
Date   Source Headline
17th Jan 20197:00 amRNSTransaction in Own Shares
14th Jan 20197:00 amRNSDirectorate Change
10th Jan 20194:37 pmRNSHolding(s) in Company
10th Jan 20197:00 amRNSTransaction in Own Shares
9th Jan 20197:00 amRNSTransaction in Own Shares
24th Dec 20187:00 amRNSTransaction in Own Shares
21st Dec 20187:00 amRNSTransaction in Own Shares
20th Dec 20187:00 amRNSTransaction in Own Shares
19th Dec 20187:00 amRNSTransaction in Own Shares
18th Dec 20187:00 amRNSTransaction in Own Shares
14th Dec 20187:00 amRNSTransaction in Own Shares
13th Dec 20187:00 amRNSShare Buy-back Programme
12th Dec 20184:18 pmRNSHolding(s) in Company
27th Nov 20187:00 amRNSHalf-year Report - six months to 30 September 2018
22nd Oct 20187:00 amRNSTrading Update and Notice of Results
19th Sep 20185:35 pmRNSHolding(s) in Company
10th Sep 20183:58 pmRNSHolding(s) in Company
4th Sep 20181:41 pmRNSDirector/PDMR Shareholding
24th Aug 20187:00 amRNSTransaction in Own Shares & TVR
23rd Aug 20184:15 pmRNSResult of AGM
23rd Aug 20187:00 amRNSDirector/PDMR Shareholding
23rd Aug 20187:00 amRNSAGM Statement
14th Aug 201811:00 amRNSPrice Monitoring Extension
14th Aug 20187:00 amRNSNew Contract Wins
6th Jul 20182:22 pmRNSHolding(s) in Company
2nd Jul 20187:00 amRNSMain Board Appointment
28th Jun 20182:45 pmRNSDirector/PDMR Shareholding
26th Jun 20187:00 amRNSFinal results -year ended 31 March & Notice of AGM
23rd Apr 20187:00 amRNSYear End Trading Update
19th Apr 20189:00 amRNSD4t4 Solutions Announces Latest Celebrus Release
10th Apr 20187:00 amRNSTrading Update and Contract Wins
26th Mar 20187:00 amRNSTransaction in Own Shares and TVR
13th Mar 20187:00 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSNew Contract Wins
12th Feb 20187:00 amRNSTransaction in Own Shares and TVR
7th Feb 20189:00 amRNSCelebrus Delivers Self-Service Solution for GDPR
2nd Feb 20187:00 amRNSTransaction in Own Shares and TVR
27th Dec 20174:40 pmRNSSecond Price Monitoring Extn
27th Dec 20174:35 pmRNSPrice Monitoring Extension
27th Dec 20177:00 amRNSNew contract wins in key vertical sectors
19th Dec 20173:45 pmRNSDirector/PDMR Shareholding
18th Dec 20177:00 amRNSTransaction in Own Shares and TVR
11th Dec 20177:00 amRNSShare Buy-backs
6th Dec 20179:05 amRNSTransaction in Own Shares and TVR
30th Nov 20177:00 amRNSDirector/PDMR Shareholding
28th Nov 20173:57 pmRNSDirector/PDMR Shareholding
28th Nov 201710:01 amRNSDirector/PDMR Shareholding
28th Nov 20179:06 amRNSSecond Price Monitoring Extn
28th Nov 20179:00 amRNSPrice Monitoring Extension
28th Nov 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.